BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23621765)

  • 1. Acute generalized exanthematous pustulosis caused by gemcitabine.
    George J; De D; Mahajan R; Saikia UN; Kanwar AJ
    Int J Dermatol; 2014 Mar; 53(3):e184-5. PubMed ID: 23621765
    [No Abstract]   [Full Text] [Related]  

  • 2. A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    Yamashita A; Fukui T; Akasaka E; Nakajima K; Nakano H; Sawamura D; Hamaya T
    J Dermatol; 2022 Aug; 49(8):e261-e263. PubMed ID: 35403293
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe neurotoxicity caused by gemcitabine treatment.
    Larsen FO; Hansen SW
    Acta Oncol; 2004; 43(6):590-1. PubMed ID: 15370618
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
    Gontero P; Marini L; Frea B
    BJU Int; 2005 Nov; 96(7):970-6. PubMed ID: 16225511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].
    Beardo Villar P; Gamaza Martínez R; Gavira Moreno R
    Farm Hosp; 2014 May; 38(3):249-51. PubMed ID: 24951911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
    Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
    J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-induced retinopathy in a diabetic patient.
    Tran TH; Desauw C; Rose C
    Acta Ophthalmol; 2009 Feb; 87(1):114-5. PubMed ID: 18577188
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report.
    Magdelaine P; Costantini A; Fabre L; Giroux-Leprieur E
    Thorac Cancer; 2022 Jul; 13(13):1994-1997. PubMed ID: 35615894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative chemotherapy: when to use it, what to use, and why.
    Johnson DC; Pruthi RS; Woods ME
    Urol Clin North Am; 2013 May; 40(2):183-95. PubMed ID: 23540777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.
    Badger J; Kang S; Uzieblo A; Srinivas S
    J Clin Oncol; 2005 Oct; 23(28):7224-5. PubMed ID: 16192608
    [No Abstract]   [Full Text] [Related]  

  • 11. Gemcitabine in bladder cancer.
    El Karak F; Flechon A
    Expert Opin Pharmacother; 2007 Dec; 8(18):3251-6. PubMed ID: 18035967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine.
    Chen YG; Lin TY; Lin GM; Lin JC
    Respir Care; 2011 Mar; 56(3):339-41. PubMed ID: 21255489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
    Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment.
    Berglund RK
    Urology; 2009 Nov; 74(5):1083; author reply 1084. PubMed ID: 19883829
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.
    De Berardinis E; Antonini G; Peters GJ; Loves WJ; Van der Born K; Codacci-Pisanelli G; Di Silverio F
    BJU Int; 2004 Mar; 93(4):491-4. PubMed ID: 15008715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.
    Campodonico F; Canepa G; Capponi G; Bozzo L; Maffezzini M
    Anticancer Res; 2005; 25(3c):2381-4. PubMed ID: 16080464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid artery inflammation associated with gemcitabine-based therapy: a special report.
    Chan A; Song M; De Guzman Langit MR; Lim TA; Fong W; Tay K; Lim ST; Tang T
    Future Oncol; 2015; 11(14):2049-58. PubMed ID: 26198835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis-like drug eruption induced by pemetrexed.
    Hattori T; Tamura A; Ishikawa O
    Eur J Dermatol; 2011; 21(6):998-9. PubMed ID: 21896401
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer].
    Matsumura E; Ashikari A; Tasaki S; Haranaga S; Toyosato T; Ashimine S; Machida N; Oshiro Y; Saito S
    Hinyokika Kiyo; 2011 Feb; 57(2):81-5. PubMed ID: 21412040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.
    Campodonico F; Mattioli F; Manfredi V; Capponi G; Pasquini P; Martelli A; Maffezzini M
    Anticancer Res; 2007; 27(2):1179-83. PubMed ID: 17465260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.